Mast Cells Regulate Wound Healing in Diabetes

Abstract

Diabetic foot ulceration is a severe complication of diabetes that lacks effective treatment. Mast cells (MCs) contribute to wound healing, but their role in diabetes skin complications is poorly understood. Here we show that the number of degranulated MCs is increased in unwounded forearm and foot skin of patients with diabetes and in unwounded dorsal skin of diabetic mice (P < 0.05). Conversely, postwounding MC degranulation increases in nondiabetic mice, but not in diabetic mice. Pretreatment with the MC degranulation inhibitor disodium cromoglycate rescues diabetes-associated wound-healing impairment in mice and shifts macrophages to the regenerative M2 phenotype (P < 0.05). Nevertheless, nondiabetic and diabetic mice deficient in MCs have delayed wound healing compared with their wild-type (WT) controls, implying that some MC mediator is needed for proper healing. MCs are a major source of vascular endothelial growth factor (VEGF) in mouse skin, but the level of VEGF is reduced in diabetic mouse skin, and its release from human MCs is reduced in hyperglycemic conditions. Topical treatment with the MC trigger substance P does not affect wound healing in MC-deficient mice, but improves it in WT mice. In conclusion, the presence of nondegranulated MCs in unwounded skin is required for proper wound healing, and therapies inhibiting MC degranulation could improve wound healing in diabetes.

Intraluminal delivery of thrombospondin‐2 small interfering RNA inhibits the vascular response to injury in a rat carotid balloon angioplasty model

“…Our data supports these findings and suggests modulating capabilities of TSP-2 on downstream regulating ECM proteins, in particular TSP-2-mediated reduction of MMP-9, which may maintain vessel circumference. In addition, convincing evidence exists that MMP-9 contributes to arterial lesion growth and impaired wound healing by regulating smooth muscle cell migration and replication (25)(26)(27). Therefore, lower MMP-9 levels might alter the severity of IH.…”

Descriptive vs mechanistic scientific approach to study wound healing and its inhibition: Is there a value of translational research involving human subjects?

“…Although the etiology of VLU, DFU and PU is multifactorial, these wounds share some common recognizable defects . These common features of non‐healing wound pathophysiology include hyperproliferative non‐migratory epidermis, unresolved inflammation, impaired fibroblasts function, extracellular matrix deposition, increased levels of proteases, decreased angiogenesis and complex microbial communities associated with biofilms …”

“…Further, the number of degranulated mast cells is shown to be greater, while substance P expression appears to be lower in non‐ulcerated diabetic forearm and dorsal foot skin. These changes influenced by diabetes may contribute to failure of proper initiation and progression of acute inflammatory response seen in DFUs . Comparison of chronic wounds to acute, healing wounds also provides important insight.…”

Mast cells and primary systemic vasculitides

“…Histamine directly contributed to beta‐cell death in isolated human islets and pancreatic cells via a caspase‐independent pathway . Chronic mast cell degranulation in the skin of diabetic subjects contributes to abnormal healing and that correcting this condition could rescue wound healing impairment …”